IRIS
CAMPIANI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.169
EU - Europa 14.899
AS - Asia 4.108
SA - Sud America 815
AF - Africa 105
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 13
Totale 37.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.052
GB - Regno Unito 4.172
IE - Irlanda 2.306
IT - Italia 2.215
CN - Cina 1.929
UA - Ucraina 1.234
SE - Svezia 1.200
SG - Singapore 1.145
RU - Federazione Russa 1.076
DE - Germania 1.028
BR - Brasile 733
FR - Francia 710
FI - Finlandia 437
HK - Hong Kong 405
IN - India 189
TR - Turchia 164
ES - Italia 104
CA - Canada 81
AT - Austria 64
CZ - Repubblica Ceca 59
CI - Costa d'Avorio 51
BE - Belgio 48
NL - Olanda 47
VN - Vietnam 32
IR - Iran 29
RO - Romania 29
AR - Argentina 27
GR - Grecia 27
PL - Polonia 26
AU - Australia 23
BD - Bangladesh 23
IQ - Iraq 17
JP - Giappone 17
MX - Messico 17
PT - Portogallo 16
EE - Estonia 14
EG - Egitto 13
UZ - Uzbekistan 13
VE - Venezuela 13
AZ - Azerbaigian 12
EU - Europa 12
IL - Israele 12
ZA - Sudafrica 12
CH - Svizzera 11
LT - Lituania 11
PK - Pakistan 11
SA - Arabia Saudita 11
CL - Cile 10
LV - Lettonia 10
MA - Marocco 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
DK - Danimarca 9
NG - Nigeria 9
CO - Colombia 8
HU - Ungheria 8
KG - Kirghizistan 8
KZ - Kazakistan 8
LA - Repubblica Popolare Democratica del Laos 8
PA - Panama 8
ID - Indonesia 7
KR - Corea 7
NZ - Nuova Zelanda 7
BG - Bulgaria 6
EC - Ecuador 6
GE - Georgia 6
JO - Giordania 6
BO - Bolivia 5
RS - Serbia 5
AL - Albania 4
AM - Armenia 4
JM - Giamaica 4
LB - Libano 4
LK - Sri Lanka 4
MY - Malesia 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
HR - Croazia 3
KH - Cambogia 3
KW - Kuwait 3
MD - Moldavia 3
PH - Filippine 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
CR - Costa Rica 2
DZ - Algeria 2
IM - Isola di Man 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
GA - Gabon 1
Totale 37.127
Salva come PNG Salva come JPEG
Città #
Southend 3.822
Fairfield 2.762
Dublin 2.286
Ashburn 1.482
Chandler 1.250
Woodbridge 1.196
Jacksonville 1.006
Seattle 986
Wilmington 979
Cambridge 927
Houston 910
Santa Clara 877
Siena 796
Ann Arbor 654
Beijing 587
Singapore 485
Hong Kong 403
Princeton 396
Nanjing 345
Boardman 181
Dearborn 164
Helsinki 162
Fremont 156
New York 149
Florence 144
San Diego 136
Izmir 134
Shanghai 133
Milan 129
Nanchang 127
Bengaluru 121
Moscow 120
San Mateo 90
Rome 88
Washington 81
Düsseldorf 80
Menlo Park 77
Málaga 77
Los Angeles 72
Shenyang 69
Hebei 68
Lappeenranta 68
Jiaxing 57
Kunming 57
São Paulo 55
Venezia 55
Lancaster 54
London 53
Abidjan 51
Redwood City 51
Munich 50
Tianjin 45
Brno 43
Brussels 43
Vienna 43
Ningbo 41
The Dalles 41
Changsha 40
Jinan 40
Norwalk 39
Frankfurt am Main 35
Aachen 34
Guangzhou 34
San Francisco 33
Council Bluffs 31
Portsmouth 31
Nuremberg 29
Toronto 27
Lauterbourg 26
Ottawa 26
Belo Horizonte 24
Dong Ket 23
Hangzhou 22
Hanover 21
Hefei 19
Philadelphia 19
Zhengzhou 19
Brescia 18
Parma 18
Trieste 17
Turin 17
Pisa 16
Prato 16
Rio de Janeiro 16
Turku 16
Dallas 15
Naples 15
Timisoara 15
Avellino 14
Brooklyn 14
Salerno 14
Taizhou 14
Brasília 13
Dhaka 13
Tashkent 13
Marietta 12
Rende 12
San Giovanni Valdarno 12
Tokyo 12
Changchun 11
Totale 26.419
Salva come PNG Salva come JPEG
Nome #
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 314
Development of novel cyclic peptides as pro-apoptotic agents 288
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents 286
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]- N -[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues 286
(S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: further exploration of bioisosteric replacements and structural and biological investigation 277
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 271
iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome 266
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies 251
Synthetic spirocyclic endoperoxides: new antimalarial scaffolds 243
Natural Compounds and Synthetic Drugs to Target FAAH Enzyme 242
Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II) 239
A new microtubule-targeting compound PBOX-15 inhibits T-cell migration via post-translational modifications of tubulin 238
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 235
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 231
First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents 231
The 1-(2,3-dichlorophenyl)-piperazine-to-aripiprazole ratio at steady state in rats and schizophrenic patients 229
Synthesis, Molecular Modelling and Biological Studies of 3-hydroxy-pyrane-4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors 227
Old but gold: tracking the new guise of Histone Deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare diseases 225
Targeting Dopamine D3and Serotonin 5-HT1Aand 5-HT2AReceptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies 224
A Jocic-type approach for a practical and scalable synthesis of pyrrolonaphthoxazepine (PNOX)-based potent proapoptotic agents 222
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 220
Identification of novel fluorescent probes preventing PrP(Sc) replication in prion diseases 219
Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking 210
1H-Cyclopentapyrimidine-2,4(1H,3H)-dione-Related Ionotropic Glutamate Receptors Ligands. Structure-Activity Relationships and Identification of Potent and Selective iGluR5 Modulators 206
Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine d3 and serotonin 5-HT 1A and 5-HT2A receptors: Design, synthesis, and effects on behavior 206
A stereoselective route to 6-substituted pyrrolo-1,5-benzoxazepinones and their analogues 204
Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase 204
Structural characterization of Giardia duodenalis thioredoxin reductase (gTrxR) and computational analysis of its interaction with NBDHEX 202
Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors 198
Selective Kainate Receptor (GluK1) Ligands Structurally Based upon 1H-Cyclopentapyrimidin-2,4(1H,3H)-dione: Synthesis, Molecular Modeling, and Pharmacological and Biostructural Characterization 198
Optimization of 4-Aminoquinoline/Clotrimazole-Based Hybrid Antimalarials: Further Structure-Activity Relationships, in vivo Studies, and Preliminary Toxicity Profiling 195
null 195
Telomerase-based cancer therapeutics: a review on their clinical trials 195
Novel quinolone-based potent and selective HDAC6 inhibitors: synthesis, molecular modeling studies and biological investigation 194
Non-Nucleoside Inhibitors of Human Adenosine Kinase: Synthesis, Molecular Modeling, and Biological Studies 190
Mimicking the Intramolecular Hydrogen Bond: Synthesis, Biological Evaluation, and Molecular Modeling of Benzoxazines and Quinazolines as Potential Antimalarial Agents 188
A light in the dark: State of the art and perspectives in optogenetics and optopharmacology for restoring vision 188
Discovery of Potent Inhibitors of Human and Mouse Fatty Acid Amide Hydrolases 188
Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold 188
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 188
Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease 187
Dopamine D3 receptor antagonists as potential therapeutics for the treatment of neurological diseases 187
Pyrrolo 1,3 benzothiazepine-based Atypical Antipsychotic Agents. Synthesis, Structure-Activity Relationship, Molecular Modeling, and Biological Studies 185
Synthetic studies toward 1,2-dioxanes as precursors of potential endoperoxide-containing antimalarials 185
Microwave-assisted synthesis of 4-quinolylhydrazines followed by nickel boride reduction: a convenient approach to 4-aminoquinolines and derivatives 185
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity 185
Cardiovascular Characterization of Pyrrolo[2,1-d][1,5]benzothiazepine Derivatives Binding Selectively to the Peripheral-Type Benzodiazepine Receptor (PBR):  From Dual PBR Affinity and Calcium Antagonist Activity to Novel and Selective Calcium Entry Blockers 185
Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D-3 and Serotonin 5-HT1A and 5-HT2A Receptors 184
Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds 183
Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors 182
Synthesis of Dihydroplakortin, 6-epi-Dihydroplakortin, and Their C10-Desethyl Analogues 182
Design and Synthesis of Potent Antimalarial Agents Based on Clotrimazole Scaffold: Exploring an Innovative Pharmacophore 182
A stereoselective approach to peptidomimetic BACE1 inhibitors 182
Synthesis and Antiplasmodial Activity of Bicyclic Dioxanes as Simplified Dihydroplakortin Analogues 181
A synthetic strategy to bridged 2,3,8-trioxabicyclo[3,3,1]nonane endoperoxides 181
Unravelling the response of chronic lymphocytic leukemia to a novel class of anticancer agents, the pyrrolonaphthoxazepines (PNOXs) 180
Harnessing the role of HDAC6 in Idiopathic Pulmonary Fibrosis: design, synthesis, structural analysis, and biological evaluation of potent inhibitors 178
Novel Ligands Specific for Mitochondrial Benzodiazepine Receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine Derivatives. Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies 175
Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1 175
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 174
Pyrroloquinoxaline Derivatives as High-Affinity and Selective 5-HT3 Receptor Agonists: Synthesis, Further Structure-Activity Relationships, and Biological Studies 173
ANTIMALARIAL AGENTS HAVING POLYAROMATIC STRUCTURE 173
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 173
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents 172
Development of Antitubercular Compounds Based on a 4-Quinolylhydrazone Scaffold. Further Structure-activity Relationship Studies 171
Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation 171
Synthetic studies toward bicyclic endoperoxides presenting polar side chains 171
Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling 171
Development of a multiplexed activity-based protein profiling assay to evaluate activity of endocannabinoid hydrolase inhibitors 171
Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent 171
Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains 170
Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model 170
A Concerted Study Using Binding Measurements, X-ray Structural Data, and Molecular Modeling on the Stereochemical Features Responsible for the Affinity of 6-Arylpyrrolo[2,1-d][1,5]benzothiazepines toward Mitochondrial Benzodiazepine Receptors 169
Pyrrolobenzoxazepinone Derivatives as Non-Nucleoside HIV-1 RT Inhibitors: Further Structure-Activity Relationship Studies and Identification of More Potent Broad-Spectrum HIV-1 RT Inhibitors with Antiviral Activity 168
Novel peptidomimetics as BACE-1 inhibitors: synthesis, molecular modeling, and biological studies 168
Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders 168
Malaria chemotherapy: recent advances in drug development 167
New Antipsychotic Agents with Serotonin and Dopamine Antagonist Properties Based on a Pyrrolo[2,1-b][1,3]benzothiazepine Structure 167
Retinitis pigmentosa and retinal degenerations: deciphering pathways and targets for drug discovery and development 167
A Comparative Molecular Field Analysis Model for 6-Arylpyrrolo[2,1-d][1,5]benzothiazepines Binding Selectively to the Mitochondrial Benzodiazepine Receptor 166
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats 166
Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors 166
A palladium-catalyzed synthetic approach to new Huperzine A analogues modified at the pyridone ring 164
Pyrrolo[2,1-c][1,4]benzothiazines: Synthesis, Structure-Activity Relationships, Molecular Modeling Studies, and Cardiovascular Activity 164
ARYL PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROPSYCHIATRY DISORDERS. 163
Computational tool for fast in silico evaluation of hERG K+ channel affinity 162
Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors 161
Discovery of Huperzine A/Tacrine Hybrids as Potent Inhibitors of Human Cholinesterases Targeting Their Mid-gorge Recognition Sites 158
Specific Targeting of Peripheral Serotonin 5-HT3 Receptors. Synthesis, Biological Investigation and Structure Activity Relationships 158
Novel aryl piperazine derivatives with medical utility 157
Pyrroloquinoxaline hydrazones as fluorescent probes for amyloid fibrils 157
Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation 156
Specific Targeting of Hepatitis C Virus NS3 RNA Helicase. Discovery of the Potent and Selective Competitive Nucleotide-Mimicking Inhibitor QU663 155
An approach to modified heterocyclic analogues of huperzine A and isohuperzine A. Synthesis of the pyrimidone and pyrazole analogues, and their anticholinesterase activity 155
New pyrrolobenzothiazepine derivatives as molecular probes of the ‘peripheral-type’ benzodiazepine receptor (PBR) binding site 154
Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents. Biological Studies and Identification of an Intracellular Location of Their Drug Target 153
A Straightforward Approach for Engineering Efficacy and Selectivity at GPCRs 152
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties 151
Site-directed mutagenesis of key residues unveiled a novel allosteric site on human adenosine kinase for Pyrrolobenzoxa(thia)zepinone non-nucleoside inhibitors 151
Specific Targeting of Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. 2. Stereoselective Interaction to Overcome the Effects of Drug Resistant Mutations 151
Totale 19.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020408 0 0 0 0 0 0 0 0 0 0 0 408
2020/20215.596 239 500 254 515 364 874 383 693 516 557 440 261
2021/20223.544 302 526 243 194 174 82 200 140 170 437 390 686
2022/20234.785 284 398 635 661 534 960 117 387 427 135 157 90
2023/20243.997 157 81 351 177 214 1.084 1.234 69 34 119 139 338
2024/20256.568 197 342 859 392 864 396 213 389 815 339 701 1.061
Totale 37.817